Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
17 November 2020Website:
http://www.revbiosciences.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | 5 min agoDividend
Analysts recommendations
Institutional Ownership
REVB Latest News
SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced safety and biomarker data for its Phase 1 clinical study (RVL-HV02). The primary endpoint to evaluate the safety and tolerability of escalating doses of Gemini was met and a maximum tolerated dose in healthy volunteers was identified.
What type of business is Revelation Biosciences?
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
What sector is Revelation Biosciences in?
Revelation Biosciences is in the Healthcare sector
What industry is Revelation Biosciences in?
Revelation Biosciences is in the Biotechnology industry
What country is Revelation Biosciences from?
Revelation Biosciences is headquartered in United States
When did Revelation Biosciences go public?
Revelation Biosciences initial public offering (IPO) was on 17 November 2020
What is Revelation Biosciences website?
https://www.revbiosciences.com
Is Revelation Biosciences in the S&P 500?
No, Revelation Biosciences is not included in the S&P 500 index
Is Revelation Biosciences in the NASDAQ 100?
No, Revelation Biosciences is not included in the NASDAQ 100 index
Is Revelation Biosciences in the Dow Jones?
No, Revelation Biosciences is not included in the Dow Jones index
When does Revelation Biosciences report earnings?
Next earnings report date is not announced yet